From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

Hon blir ny vd för Chalmers ägarstiftelse

Sara Wallin har fått uppdraget att ta över vd-posten för stiftelsen Chalmers tekniska högskola.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

Column: "Are we already living in the new normal?"

2020 felt like the year that we were building the house around us whilst moving into it at the same time.

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

Elisabet Lann blir ny sjukvårdsminister

Efter det plötsliga avhoppet står det nu klar att Elisabet Lann (KD) blir ny sjukvårdsminister.

Studie: Omtalat diabetesläkemedel kan ha effekt mot leversjukdom

Efter framgångarna inom diabetes och viktminskning – nu pekas ytterligare ett potentiellt terapiområde ut för Ozempic och andra GLP1-analoger. I en ny studie ko...

Krönika: Collaboration across borders

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Study: Semaglutide tablet produces weight loss

The pharmaceutical semaglutide is effective for weight loss even when given in tablet form, according to a phase 3 study.

Ny vd för Sahlgrenska Science Park

Cellinks nuvarande vd, Cecilia Edebo, rekryteras till Sahlgrenska Science Park. I början av nästa år tar hon över vd-posten.

Vinnova is going to establish a new innovation cluster

Vinnova, the Swedish Agency for Innovation Systems, has been commissioned by the government to establish a national innovation cluster for advanced medicines.

The route to vaccines for everyone: “We did not just sit around and wait”

The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a propos...

Biosergens vd kliver av – hon är hans ersättare

Biotechbolaget Biosergen, som utvecklar antifungala terapier, gör ett skifte på vd-posten. Peder M Andersen slutar efter sex år och ersätts av Tine Olesen.

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.

Forskningscenter stoppas på grund av brister – ”Väldigt allvarligt”

Forskning som bedrivs utan tillstånd. Bristande kvalitetssäkring. Personuppgifter som hanteras felaktigt. Kritiken mot arbetet på Center for Bionics and Pain Re...

Skånskt bolag siktar på att bli ledande inom mitokondriell medicin

Abliva är ett av få bolag som utvecklar läkemedel mot primär mitokondriell sjukdom. Life Science Sweden besökte bolaget i Medicon Village lokaler i Lund.

This is the future location of the new national innovation cluster

Mölndal and Goco Health Innovation City will be the site of a new national innovation cluster for advanced therapies. The business community and the Swedish gov...

CCRM Nordic rekryterar vetenskaplig chef

Anna Falk, professor vid Lunds universitet, blir Chief Scientific Officer på CCRM Nordic.

CTR förvärvar kontraktsforskningsbolag

Bolagsgruppen Center for Translational Research, CTR, utökar sin portfölj inom bland annat farmakovigilans genom förvärv av kontraktsforskningsbolaget A+ Science.

Lundaforskare tilldelas pris från Novo Nordisk Foundation

Hindrik Mulder, professor vid Lunds universitet, får Novo Nordisk Foundation Lecture Prize för sin forskning på diabetes.